Skye Bioscience Responds to OTC Markets Promotional Policy
San Diego, California--(Newsfile Corp. - December 8, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical...
Pharmaceutical
Cosmos Health to Participate at Capital Link’s ‘Invest in Greece’ Forum in New York
CHICAGO, IL / ACCESSWIRE / December 8, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
GE HealthCare Announces Cash Dividend for Fourth Quarter of 2023
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.03 per...
Update on Reverse Acquisition – PMD Completes Private Placement and Major Shareholder Receives Exemption from Mandatory Bid Requirements
STOCKHOLM, SE / ACCESSWIRE / December 8, 2023 / Promore Pharma (STO:PROMO)(FRA:8T0) Promore Pharma AB (publ) (the "Company" or "Promore")...
iZafe Group has Won Procurement for Pharmaceutical Robots Potentially Worth SEK 5.5-13.8 million
STOCKHOLM, SWEDEN / ACCESSWIRE / December 8, 2023 / iZafe Group (STO:IZAFE-B) ("iZafe Group") announces that it has been awarded...
BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Jarmo Halonen
BBS-Bioactive Bone Substitutes Plc, Company announcement, Management transactions, 8 December 2023 at 3.30 p.m. (EET) BBS-Bioactive Bone Substitutes Oyj -...
BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Oili Halonen
BBS-Bioactive Bone Substitutes Plc, Company announcement, Management transactions, 8 December 2023 at 3.30 p.m. (EET) BBS-Bioactive Bone Substitutes Oyj -...
Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers
CHICAGO, IL / ACCESSWIRE / December 7, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
SEQSTER Launches CoRD™ (Connected Research & Development) Accelerating Drug Discovery and Deep Insights for Pharma
Eliminate data silos and streamline workflows to improve operational efficiencySAN DIEGO--(BUSINESS WIRE)--Seqster PDM, Inc. ("SEQSTER") , the industry leading patient-centric...
SEQSTER Launches CoRD™ (Connected Research & Development) Accelerating Drug Discovery and Deep Insights for Pharma
Eliminate data silos and streamline workflows to improve operational efficiencySAN DIEGO--(BUSINESS WIRE)--Seqster PDM, Inc. ("SEQSTER") , the industry leading patient-centric...
Kymera Therapeutics Announces First Patient Dosed in Phase 2 Atopic Dermatitis Clinical Trial of KT-474 (SAR444656), a First-in-Class, Investigational IRAK4 Degrader, Generating a $15 Million Payment from Sanofi
Atopic Dermatitis (AD) trial is the second KT-474 Phase 2 clinical trial to begin enrolling patients this quarter following trial...
MASCC (Multinational Association of Supportive Care in Cancer) Webinar on GI Toxicities from Cancer Therapies Made Possible by Grant From Napo Pharmaceuticals, a Jaguar Health Family Company
To register for the webinar, click hereSAN FRANCISCO, CA / ACCESSWIRE / December 7, 2023 / Napo Pharmaceuticals (Napo), a...
Compass Pathways appoints Teri Loxam as Chief Financial Officer
LONDON, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient...
TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations
WALTHAM, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the...
AlzeCure Presents at Redeye Investor Forum in Göteborg on December 14
STOCKHOLM, SE / ACCESSWIRE / December 07, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical...
HFS Research recognizes CitiusTech as a Market Leader in Horizons Report: Life Sciences Service Provider 2023
PRINCETON, N.J.--(BUSINESS WIRE)--#CitiusTech--CitiusTech, a leading provider of healthcare technology services, solutions, and platforms, has been recognized as a Market Leader...
HFS Research recognizes CitiusTech as a Market Leader in Horizons Report: Life Sciences Service Provider 2023
PRINCETON, N.J.--(BUSINESS WIRE)--#CitiusTech--CitiusTech, a leading provider of healthcare technology services, solutions, and platforms, has been recognized as a Market Leader...
Americord Elevates Standards With Strategic Lab Relocation to Somerset, New Jersey
SOMERSET, NJ / ACCESSWIRE / December 6, 2023 / Americord, a leader in the biobanking industry, has moved its in-house...
Americord Elevates Standards With Strategic Lab Relocation to Somerset, New Jersey
SOMERSET, NJ / ACCESSWIRE / December 6, 2023 / Americord, a leader in the biobanking industry, has moved its in-house...
How CNS Pharmaceuticals Is Taking A Different Approach To Find A Treatment For Glioblastoma, A Cancer With A Poor Prognosis And No Cure
HOUSTON, TX / ACCESSWIRE / December 6, 2023 / Every form of cancer is devastating, but the unfortunate reality is...